Ketan R. Patel
Ketan Patel | |
|---|---|
 Patel in 2019 | |
| Born | Ketan Rajnibhai Patel |
| Alma mater | |
| Occupation(s) | Pharmacist, businessman |
Ketan R. Patel (also known as Ketan Rajnibhai Patel) is an Indian pharmacist, innovator, and serves as the chairman & managing director of Troikaa Pharmaceuticals Ltd., a pharmaceutical company headquartered in Gujarat, India.[1]
Education & career
[edit]Patel earned Gold Medals during both his Bachelor of Pharmacy and Master of Pharmacy programs from L. M. College of Pharmacy, Ahmedabad. He received a Ph.D. in Pharmaceutical Technology, which he obtained from Dharamsinh Desai University, Gujarat.[2]
Patel established the "Rajnibhai.V. Patel Pharmlnnova Award" under the aegis of the Department of Science and Technology (India).[3][4]
Details of his career are documented in the book titled 'THE INNOVATORS,' published by the Department of Science and Technology (India) Government of India.[5]
Membership and boards
[edit]Patel held the position of chairman of the Board of Governors at NIPER, Ahmedabad[6] and also served as a member of the Board of Governors for Gujarat Technological University.[7][8] He is also a member of the Academic Council at National Forensic Sciences University, Ahmadabad (Also known as Gujarat Forensic Sciences University).[9]
He also serves as a member of the Board of Directors at i-HUB, one of the biggest startup institutes established by the Government of Gujarat.[10]
Patel is the chairman of the Board of Governors at National Institute of Pharmaceutical Education & Research (NIPER), Gandhinagar.[11]
Invention
[edit]Patel is the primary inventor and patent holder of a painless diclofenac injection marketed under the brand name 'DYNAPAR-AQ' by Troikaa Pharmaceuticals Ltd. His innovation earned recognition from the Government of India’s Department of Science & Industrial Research, which honored him with the National Award in 2008.[12][13]
In 2008, he invented a quick, powerful & long-lasting penetrating solution of Diclofenac designed for Topical administration known as “Dynapar QPS”, for which he was conferred with a National Award in 2015 from the Department of Science & Technology, Govt of India.[14]
In 2019, he introduced a solution for Vitamin B12 deficiency. NasoB12, the world's first globally approved nasal drug delivery system, utilizes Methylcobalamin, the biologically active form of Vitamin B12, to effectively address Vitamin B12 deficiency, which has high prevalence in India and developing nations. NASO B12 was honored with the "India Star Award" for outstanding packaging design. This award was provided by the Indian Institute of Packaging, an autonomous body operating under the aegis of the Ministry of Commerce and Industry, Government of India.[15][16]
In 2023, Xykaa IM, world’s first 500mg Paracetamol/2ml injection was introduced by Ketan Patel and Milan Patel. This is a medicine for rapid control of high fever. It provides quick potent fever relief with 72% higher bio availability than oral Paracetamol.[17][18]
Awards and honors
[edit]
- National Award by Department of Scientific & Industrial Research (DSIR) in 2011, facilitated by former President of India – A.P.J. Abdul Kalam for R&D efforts
Publications
[edit]- PENETRATION OF DICLOFENAC FROM NOVEL QUICK PENETRATING SOLUTION. A COMPARATIVE SCINTIGRAPHY STUDY WITH GEL, Sanjaykumar H. Maroo, Ketan R. Patel and Aseem Bhatnagar, International Journal of Pharma & Science Res.2013;5(4):175-178
- A Comparative Dermal Microdialysis Study of Diclofenac QPS versus Conventional 1% Diclofenac Gel Archived 2019-10-29 at the Wayback Machine, Sanjay Kumar H. Maroo1*, Ketan R. Patel, Vipul Prajapati, Rajen Shah, Milind Bagul, ISSN 0975-248X, 2013, vol5, issue4
- Comparison of Heparin Quick Penetrating Solution and Diclofenac Quick Penetrating Solution for the Prevention of Superficial Thrombophlebitis Caused by Peripheral Venous Cannulation: A Randomized Double-Blind Study, Akhileshwar and Swati Singh, doi: 10.4103/aer.AER_189_18, 2019 Jan-Mar; 13(1): 155–157, PMID 31031497
- Evaluation of Skin Penetration of Diclofenac from a Novel Topical Non Aqueous Solution: A Comparative Bioavailability Study, Manish Nivsarkar, Sanjaykumar Maroo, Ketan R Patel, Dixit D Patel, ISSN: 0975-8232, 2017
References
[edit]- ^ Talukdar, Tapash (8 September 2008). "The pain killer". The Economic Times.
- ^ "L M COLLEGE OF PHARMACY M.PHARM. ALUMNI (1956-2013)" (PDF). lmcp.in. Archived from the original (PDF) on 2018-07-13. Retrieved 2019-12-20.
- ^ "Award" (PDF). .tnmgrmu.ac.in.
- ^ "Home : PharmInnova Award". www.innovativethesisaward.org. Archived from the original on 2020-02-04. Retrieved 2019-12-20.
- ^ Awasthi, Dinesh Narain; Joshi, Rajiv (2015). "The Innovators: Stories of Hi-tech Entrepreneurs". Centre for Policy Research in Science & Technology Entrepreneurship, Entrepreneurship Development Institute of India.
- ^ "Ketanbhai Rajnibhai Patel vs State Of Gujarat on 4 September, 2019". indiankanoon.org.
- ^ "Gujarat Technological University". www.gtu.ac.in.
- ^ "Academic Council – Gujarat Forensic Sciences University". Gfsu. Archived from the original on 2020-09-20. Retrieved 2019-12-20.
- ^ "Gujarat Technological University". www.gtu.ac.in.
- ^ "i-Hub - A Government of Gujarat Initiative". ihubgujarat.in.
- ^ "Ketanbhai Rajnibhai Patel vs State Of Gujarat on 4 September, 2019". indiankanoon.org.
- ^ "Ketanbhai Rajnibhai Patel vs State Of Gujarat on 4 September, 2019". Indiankanoon.
- ^ "Injectable preparations of diclofenic and its pharmaceutically acceptable salts". Patent Google. 30 January 2006.
- ^ "A non-aqueous topical solution of diclofenac and process for preparing the same".
- ^ "Troikaa Pharma with its indigenised B12 nasal spray sees doctors prefer simple ways to offset B-12 deficiency". Pharmabiz.
- ^ "WIPO - Search International and National Patent Collections". patentscope.wipo.int.
- ^ "DPCO impact: Revenue of local pharma players may dip". Business Standard.
- ^ "WO2012001494 - PHARMACEUTICAL COMPOSITIONS COMPRISING PARACETAMOL AND PROCESS FOR PREPARING THE SAME". patentscope.wipo.int.